Viloxazine

A review of the literature

T. A. Ban, Joseph Patrick McEvoy, W. H. Wilson

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

Original languageEnglish (US)
Pages (from-to)118-123
Number of pages6
JournalInternational Pharmacopsychiatry
Volume15
Issue number2
DOIs
StatePublished - Jan 1 1980
Externally publishedYes

Fingerprint

Viloxazine
Imipramine
Amitriptyline
Antidepressive Agents
Clinical Trials
Pharmacology
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Viloxazine : A review of the literature. / Ban, T. A.; McEvoy, Joseph Patrick; Wilson, W. H.

In: International Pharmacopsychiatry, Vol. 15, No. 2, 01.01.1980, p. 118-123.

Research output: Contribution to journalReview article

Ban, T. A. ; McEvoy, Joseph Patrick ; Wilson, W. H. / Viloxazine : A review of the literature. In: International Pharmacopsychiatry. 1980 ; Vol. 15, No. 2. pp. 118-123.
@article{f4772a04f49e4d9d995e90297028ad87,
title = "Viloxazine: A review of the literature",
abstract = "In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.",
author = "Ban, {T. A.} and McEvoy, {Joseph Patrick} and Wilson, {W. H.}",
year = "1980",
month = "1",
day = "1",
doi = "10.1159/000468422",
language = "English (US)",
volume = "15",
pages = "118--123",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Viloxazine

T2 - A review of the literature

AU - Ban, T. A.

AU - McEvoy, Joseph Patrick

AU - Wilson, W. H.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

AB - In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

UR - http://www.scopus.com/inward/record.url?scp=0018966986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018966986&partnerID=8YFLogxK

U2 - 10.1159/000468422

DO - 10.1159/000468422

M3 - Review article

VL - 15

SP - 118

EP - 123

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 2

ER -